87230198

Information

• Trademark
• 87230198

• Source

• Serial Number

  87230198

• Registration Number

  5367684

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 08, 2016
  8 years ago

• Registration Date

  January 02, 2018
  7 years ago

• Transaction Date

  August 20, 2024
  7 months ago

• Status Date

  July 12, 2024
  8 months ago

• Published for Opposition Date

  October 17, 2017
  7 years ago

• Location Date

  January 02, 2018
  7 years ago

• Status Code

  710

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BRECKENFELD, WILLIAM G

• Attorney Docket Number

  AJO2-301-TM

  Attorney Name

  Molly B. Markley

  Law Office Assigned Location Code

  M70

• Owners

  • Vectura GmbH

Case File Statements

• DM0000: The mark consists of seven horizontal lines growing in thickness and shrinking in length to form the shape of a triangle.
• GS0051: Pharmaceutical and biological preparations for medical purpose, namely, for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely, the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely, for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely, for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely, for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely, medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, and medicaments for the treatment of asthma
• CC0000: Color is not claimed as a feature of the mark.
• GS0101: Drug delivery devices, namely, drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods
• GS0421: Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing, namely, device and product testing of drug delivery devices and medical preparations

Case File Event Statements

• 11/11/2016 - 8 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 11/14/2016 - 8 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 2/14/2017 - 8 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 11/15/2016 - 8 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 2/15/2017 - 8 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/27/2017 - 7 years ago

  13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/17/2017 - 7 years ago

  14 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/17/2017 - 7 years ago

  15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/2/2018 - 7 years ago

  16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 1/2/2023 - 2 years ago

  17 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1

• 7/12/2024 - 8 months ago

  18 - CANCELLED SEC. 8 (6-YR) Type: C8..

• 9/12/2017 - 7 years ago

  12 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 2/15/2017 - 8 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 2/15/2017 - 8 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/20/2017 - 7 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/14/2017 - 7 years ago

  9 - ASSIGNED TO LIE Type: ALIE

• 8/15/2017 - 7 years ago

  10 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/15/2017 - 7 years ago

  11 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME